AVM
Arch Venture Management Portfolio holdings
AUM
$299M
1-Year Return
19.47%
This Quarter Return
-25.93%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$100M
AUM Growth
–
Cap. Flow
+$100M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
+$42.1M |
| 2 |
Fate Therapeutics
FATE
|
+$26.6M |
| 3 |
Kura Oncology
KURA
|
+$26.1M |
| 4 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
+$3.72M |
| 5 |
BLPH
Bellerophon Therapeutics, Inc.
BLPH
|
+$774K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
| $42.1M | 42.09% |
+2,618,351
| New | +$42.1M |
|
|
2
Fate Therapeutics
FATE
$111M
| $26.6M | 26.59% |
+2,073,190
| New | +$26.6M |
|
|
3
Kura Oncology
KURA
$711M
| $26.1M | 26.06% |
+1,856,307
| New | +$26.1M |
|
|
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $3.72M | 3.72% |
+1,196,776
| New | +$3.72M |
|
|
BLPH
5
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $774K | 0.77% |
+64,377
| New | +$774K |
|
|
AKAO
6
DELISTED
Achaogen, Inc.
AKAO
| $768K | 0.77% |
+624,544
| New | +$768K |
|